Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research.

Z. Eshhar, G. Gross, Chimeric T cell receptor which incorporates the anti-tumour specificity of a monoclonal antibody with the cytolytic activity of T cells: a model system for immunotherapeutical approach. The British journal of cancer. Supplement. ,vol. 10, pp. 27- 29 ,(1990)

Raffaella Greco, Giacomo Oliveira, Maria Teresa Lupo Stanghellini, Luca Vago, Attilio Bondanza, Jacopo Peccatori, Nicoletta Cieri, Sarah Marktel, Sara Mastaglio, Claudio Bordignon, Chiara Bonini, Fabio Ciceri, Improving the safety of cell therapy with the TK-suicide gene Frontiers in Pharmacology. ,vol. 6, pp. 95- 95 ,(2015) , 10.3389/FPHAR.2015.00095

Enkhtsetseg Purev, Dewei Cai, Eric Miller, Rolf Swoboda, Ted Mayer, Andres Klein-Szanto, Francesco M. Marincola, Rosemarie Mick, Laszlo Otvos, William Wunner, Brigitte Birebent, Rajasekharan Somasundaram, Carol J. Wikstrand, Darell Bigner, Angela DeMichele, Geza Acs, Jesse A. Berlin, Dorothee Herlyn, Immune Responses of Breast Cancer Patients to Mutated Epidermal Growth Factor Receptor (EGF-RvIII, ΔEGF-R, and de2–7 EGF-R) Journal of Immunology. ,vol. 173, pp. 6472- 6480 ,(2004) , 10.4049/JIMMUNOL.173.10.6472

Donata Rimoldi, Danila Valmori, Danielle Liénard, Jean-Charles Cerottini, Gary Waanders, Pedro Romero, Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients. Cancer Research. ,vol. 57, pp. 735- 741 ,(1997)

Jianfeng Han, Jianhong Chu, Wing Keung Chan, Jianying Zhang, Youwei Wang, Justus B Cohen, Aaron Victor, Walter H Meisen, Sung-hak Kim, Paola Grandi, Qi-En Wang, Xiaoming He, Ichiro Nakano, E Antonio Chiocca, Joseph C Glorioso III, Balveen Kaur, Michael A Caligiuri, Jianhua Yu, None, CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells. Scientific Reports. ,vol. 5, pp. 11483- 11483 ,(2015) , 10.1038/SREP11483

Gordon Li, Albert J Wong, EGF receptor variant III as a target antigen for tumor immunotherapy Expert Review of Vaccines. ,vol. 7, pp. 977- 985 ,(2008) , 10.1586/14760584.7.7.977

Scott Wilkie, May C. I. van Schalkwyk, Steve Hobbs, David M. Davies, Sjoukje J. C. van der Stegen, Ana C. Parente Pereira, Sophie E. Burbridge, Carol Box, Suzanne A. Eccles, John Maher, Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling Journal of Clinical Immunology. ,vol. 32, pp. 1059- 1070 ,(2012) , 10.1007/S10875-012-9689-9

Etienne Joly, Denis Hudrisier, What is trogocytosis and what is its purpose Nature Immunology. ,vol. 4, pp. 815- 815 ,(2003) , 10.1038/NI0903-815

Maria R Parkhurst, James C Yang, Russell C Langan, Mark E Dudley, Debbie-Ann N Nathan, Steven A Feldman, Jeremy L Davis, Richard A Morgan, Maria J Merino, Richard M Sherry, Marybeth S Hughes, Udai S Kammula, Giao Q Phan, Ramona M Lim, Stephen A Wank, Nicholas P Restifo, Paul F Robbins, Carolyn M Laurencot, Steven A Rosenberg, T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis Molecular Therapy. ,vol. 19, pp. 620- 626 ,(2011) , 10.1038/MT.2010.272

Nicolai Aagaard Schultz, Anne Roslind, Ib J. Christensen, Thomas Horn, Estrid Høgdall, Lisbeth N. Pedersen, Mogens Kruhøffer, Flemming Burcharth, Morten Wøjdemann, Julia S. Johansen, Frequencies and prognostic role of KRAS and BRAF mutations in patients with localized pancreatic and ampullary adenocarcinomas. Pancreas. ,vol. 41, pp. 759- 766 ,(2012) , 10.1097/MPA.0B013E31823CD9DF